Navigation Links
Lipitor Lawsuit News: Rottenstein Law Group LLP Responds to Reports of Lipitor Giveaway
Date:5/29/2013

Philadelphia, Penn. (PRWEB) May 29, 2013

Grocery chain Wegmans, looking to gain market share, is giving out free generic Lipitor to customers to whom the drug has been prescribed by doctors, according to the Philadelphia Inquirer.* The Rottenstein Law Group LLP, which manages the Lipitor Lawsuit Center at http://www.lipitorlawyer.us, is concerned by this promotion and notes an alleged link between Lipitor and an increased risk of type-2 diabetes in women who use the drug to lower their cholesterol levels.

The supermarket business is competitive, and Wegmans was looking for an edge over its competitors, according to the Inquirer story. The promotion was intended to end in April 2013, but the chain extended it through December.

“Inexpensive healthcare can be beneficial, but studies have shown that Lipitor—including generic versions—has serious side effects,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “It is important to keep in mind that there are several people who have filed Lipitor lawsuits across the nation because of these.”

Rottenstein was referring to at least two studies that link Lipitor use and diabetes. A 2011 study published in the Journal of the American College of Cardiology found the general relationship, and a study published in the January 2012 edition of JAMA: Internal Medicine highlighted the risk for women.**

Plaintiffs across the country who have taken Lipitor are filing lawsuits, many of which are under consideration for consolidation into a federal multidistrict litigation for pretrial proceedings (In re Lipitor (Atorvastatin) Litigation, MDL No. 2459 (JPML)).

The Rottenstein Law Group LLP encourages those who have taken Lipitor to visit this page for a free informational brochure that discusses Lipitor side effects and how to file a Lipitor lawsuit.

*articles.philly.com/2013-03-14/business/37685352_1_lipitor-atorvastatin-generic-drugs (March 14, 2013)

**archinte.jamanetwork.com/article.aspx?articleid=1108676 9 (January 2012)

For the latest news on defective medications and medical devices and related lawsuits, visit the Rottenstein Law Group LLP’s Injury Lawyer Newswire at injurylawyernewswire.com. Readers can subscribe to the news site’s stories and videos to stay on top of personal injury news.

About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and drugs. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com

Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb10780659.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lipitor Diabetes Lawsuit Filed by South Carolina Woman Who Developed Type 2 Diabetes Allegedly Due to Lipitor Use, Alonso Krangle Investigating
2. Lipitor Lawsuit News: Rottenstein Law Group Comments on FDA Approval of New Drug With Lipitor Compound
3. Lipitor Lawsuit News: US Spending on Drugs Fell For First Time in 2012, Notes Rottenstein Law Group LLP
4. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
5. The Law Office of Wolf & Pravato, The Alters Firm and Morelli Ratner File Class Action Lawsuit Against Global Spray Foam Manufacturer
6. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
7. New Lawsuit Alleges Teen Molestation by Ex-Deputy
8. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
9. New Lawsuit on Propecia: Severe Adverse Events
10. New Lawsuit on Accutane Crohn’s Disease: Severe Adverse Events
11. New Lawsuit alleges Actos caused Bladder Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... ... Month and the focus is on prostate cancer. Second only to skin cancer, prostate ... common cause of cancer related death today; lung cancer remains in the number one spot. ... during his lifetime. Those at highest risk are men who have a family ...
(Date:6/24/2017)... ... ... Doorknobs are for convenience, deadbolts are for security. , There are many ... an alarm system installed. But unless there is a working deadbolt lock that is ... Premier Locksmith in Killeen, TX says: “In the majority of home burglaries, intruders use ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids and antioxidants derived ... loss in these patients. , But how often do ophthalmologists and optometrists in Sweden ... at risk of or with early symptoms of AMD? A study published recently ...
(Date:6/23/2017)... ... ... Goodcents Deli Fresh Subs today announced the opening of a new restaurant ... Topeka, Kan. 66604 (near 21st and Gage). It is owned and operated by long-time ... in the Topeka and Bonner Springs, Kan. area. , “Goodcents has such a ...
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent ... is MD Now’s 28th facility overall and marks the urgent care center's eighth location ... mile North of The Falls shopping mall. The new clinic offers a wide array ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... -- Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: APOP), ... selection of stem cells, today provided a corporate update ... March 31 st , 2017. "We ... quarter of 2017," said Dr. Shai Yarkoni, Chief Executive ... of the first blood cancer patient in the recently ...
Breaking Medicine Technology: